Discounted Cash Flow (DCF) Analysis Levered
Spectral Medical Inc. (EDT.TO)
$0.305
+0.01 (+3.39%)
All numbers are in Millions, Currency in USD
Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 3.81 | 3.84 | 2.87 | 2.10 | 2.05 | 1.78 | 1.54 | 1.33 | 1.16 | 1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue (%) | ||||||||||
| Operating Cash Flow | -3.60 | -2.32 | -2.74 | -0.32 | -8.70 | -2.45 | -2.12 | -1.84 | -1.59 | -1.38 |
| Operating Cash Flow (%) | ||||||||||
| Capital Expenditure | -0.13 | -0.05 | -0.16 | -0.32 | -0.48 | -0.17 | -0.15 | -0.13 | -0.11 | -0.10 |
| Capital Expenditure (%) | ||||||||||
| Free Cash Flow | -3.73 | -2.37 | -2.90 | -0.64 | -9.18 | -2.63 | -2.28 | -1.97 | -1.71 | -1.48 |
Weighted Average Cost Of Capital
| Share price | $ 0.305 |
|---|---|
| Beta | 0.988 |
| Diluted Shares Outstanding | 252.46 |
| Cost of Debt | |
| Tax Rate | 0.00 |
| After-tax Cost of Debt | 4.81% |
| Risk-Free Rate | |
| Market Risk Premium | |
| Cost of Equity | 8.353 |
| Total Debt | 0.58 |
| Total Equity | 77 |
| Total Capital | 77.58 |
| Debt Weighting | 0.75 |
| Equity Weighting | 99.25 |
| Wacc |
Build Up Free Cash Flow
Year A/P | 2017 Actual | 2018 Actual | 2019 Actual | 2020 Actual | 2021 Actual | 2022 Projected | 2023 Projected | 2024 Projected | 2025 Projected | 2026 Projected |
| Revenue | 3.81 | 3.84 | 2.87 | 2.10 | 2.05 | 1.78 | 1.54 | 1.33 | 1.16 | 1 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | -3.60 | -2.32 | -2.74 | -0.32 | -8.70 | -2.45 | -2.12 | -1.84 | -1.59 | -1.38 |
| Capital Expenditure | -0.13 | -0.05 | -0.16 | -0.32 | -0.48 | -0.17 | -0.15 | -0.13 | -0.11 | -0.10 |
| Free Cash Flow | -3.73 | -2.37 | -2.90 | -0.64 | -9.18 | -2.63 | -2.28 | -1.97 | -1.71 | -1.48 |
| WACC | ||||||||||
| PV LFCF | -2.42 | -1.94 | -1.55 | -1.24 | -0.99 | |||||
| SUM PV LFCF | -8.14 |
Terminal Value
| Growth in perpetuity method: | |
|---|---|
| Long-term growth rate | |
| WACC (%) | 8.33 |
| Free cash flow (t + 1) | -1.51 |
| Terminal Value | -23.83 |
| Present Value of Terminal Value | -15.97 |
Intrinsic Value
| Enterprise Value | -24.12 |
|---|---|
| Net Debt | -8.31 |
| Equity Value | -15.81 |
| Shares Outstanding | 252.46 |
| Equity Value Per Share | -0.06 |